Posted inBiotechnology
How Cells Determine When to Respond Could Transform Future Cancer and Fibrosis Treatments
Cells are not only able to sense physical forces in their environment but also possess an intrinsic ability to measure…
Posted inBiotechnology
Breakthrough or Mystery? The Enigma of Unexpected Superconductivity
In the realm of quantum materials, few substances challenge scientific understanding quite like uranium ditelluride, or UTe2. This exotic compound…
Posted inBiotechnology
New Study Revolutionizes Understanding of mRNA Vaccines and Introduces Breakthrough Method to Enhance Their Effectiveness
In a groundbreaking study published on April 29, 2026, in the prestigious journal Nature Biotechnology, a team of researchers from…
Posted inBiotechnology
AstraZeneca restarts £300M investment in UK, but Merck not budging
AstraZeneca will resume a 300 million pound ($404 million) investment program in the U.K. seven months after freezing the plans…
Posted inBiotechnology
Teva inks $700M Emalex buyout to bag near-approval Tourette drug
Teva Pharmaceuticals has struck a deal to buy Emalex Biosciences for $700 million upfront, positioning the drugmaker to advance a Tourette…
Posted inBiotechnology
AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial
AstraZeneca has scrapped an asthma program after the FLAP inhibitor flopped in a phase 2 trial. The U.K.-based Big Pharma…
Posted inBiotechnology
Remote Ischaemic Postconditioning Enhances Hypothermia for Encephalopathy
In an era where pediatric neurological emergencies demand innovative approaches, a new study published in Pediatric Research on April 29,…
Posted inBiotechnology
Which blockbuster is GSK gunning for next? CEO Miels is looking to oncology
When it comes to GSK’s new dealmaking strategy of trying to outdo established blockbusters, CEO Luke Miels has told Fierce…
Posted inBiotechnology
KERI Overcomes Interfacial Instability Challenges in Commercializing All-Solid-State Batteries
In a groundbreaking development poised to redefine the future of energy storage, researchers at the Korea Electrotechnology Research Institute (KERI)…
Posted inBiotechnology
GSK walks away from $100M bet on Mersana’s STING ADC, pauses mRNA bird flu shot program
GSK has finally called time on its pact with Mersana Therapeutics despite sinking $100 million to secure an option for…